Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Is Associated with Indigenous American Ancestry in Latin American Women
- 1 May 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 80 (9), 1893-1901
- https://doi.org/10.1158/0008-5472.can-19-3659
Abstract
Women of Latin American origin in the United States are more likely to be diagnosed with advanced breast cancer and have a higher risk of mortality than non-Hispanic White women. Studies in U.S. Latinas and Latin American women have reported a high incidence of HER2 positive (+) tumors; however, the factors contributing to this observation are unknown. Genome-wide genotype data for 1,312 patients from the Peruvian Genetics and Genomics of Breast Cancer Study (PEGEN-BC) were used to estimate genetic ancestry. We tested the association between HER2 status and genetic ancestry using logistic and multinomial logistic regression models. Findings were replicated in 616 samples from Mexico and Colombia. Average Indigenous American (IA) ancestry differed by subtype. In multivariate models, the odds of having an HER2+ tumor increased by a factor of 1.20 with every 10% increase in IA ancestry proportion (95% CI, 1.07–1.35; P = 0.001). The association between HER2 status and IA ancestry was independently replicated in samples from Mexico and Colombia. Results suggest that the high prevalence of HER2+ tumors in Latinas could be due in part to the presence of population-specific genetic variant(s) affecting HER2 expression in breast cancer. Significance: The positive association between Indigenous American genetic ancestry and HER2+ breast cancer suggests that the high incidence of HER2+ subtypes in Latinas might be due to population and subtype-specific genetic risk variants.Keywords
Other Versions
Funding Information
- National Cancer Institute (R01CA204797)
- National Cancer Institute (P30CA093372)
- Sistema Nacional de Regalias (520120516, 520115)
This publication has 52 references indexed in Scilit:
- Admixture mapping identifies a locus on 6q25 associated with breast cancer risk in US LatinasHuman Molecular Genetics, 2012
- Early onset HER2‐positive breast cancer is associated with germline TP53 mutationsCancer, 2011
- Disparities in breast cancer characteristics and outcomes by race/ethnicityBreast Cancer Research and Treatment, 2010
- A novel HER2-positive breast cancer phenotype arising from germline TP53 mutationsJournal of Medical Genetics, 2010
- Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 StudiesPLoS Medicine, 2010
- Breast Cancer Subtypes as Defined by the Estrogen Receptor (ER), Progesterone Receptor (PR), and the Human Epidermal Growth Factor Receptor 2 (HER2) among Women with Invasive Breast Cancer in California, 1999-2004The Breast Journal, 2009
- Fast model-based estimation of ancestry in unrelated individualsGenome Research, 2009
- Genetic Ancestry and Risk of Breast Cancer among U.S. LatinasCancer Research, 2008
- Allele-Specific Amplification in Cancer Revealed by SNP Array AnalysisPLoS Computational Biology, 2005
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003